Spots Global Cancer Trial Database for A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
Official Title: A Trial of Thymalfasin With Trans Arterial Chemo-Embolization (TACE) in the Treatment of Adult Patients With Unresectable Hepatocellular Carcinoma: A Phase II Trial
Study ID: NCT00082082
Conditions
Study Description
Brief Summary: The objective of this Phase II trial is to compare the efficacy and safety of 6 months of treatment with thymalfasin plus trans arterial chemoembolization (TACE) with TACE alone in adult patients with non-surgical hepatocellular carcinoma (HCC).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
California Pacific Medical Center, San Francisco, California, United States
University of Florida, Gainesville, Florida, United States
William Beaumont Hospital, Royal Oak, Michigan, United States
Columbia University, New York, New York, United States
Metropolitan Research, Fairfax, Virginia, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
